PMLiVE

About PMLiVE

PMLiVE is the digital news platform of PMGroup, the UK-based publishing and communications company serving the pharmaceutical industry. Launched in 1999, it provides daily news, features and analysis for pharma professionals — covering marketing, market access, digital innovation and industry strategy — and is closely associated with the prestigious PMEA (Pharmaceutical Marketing Excellence Awards) and PME awards. Visit the official website at pmlive.com.

History and founding

PMLiVE was launched in 1999 as the online news arm of PMGroup Worldwide Ltd, the pharmaceutical publishing and healthcare communications company. It arrived early in the digital transformation of B2B media, establishing a daily news presence for the pharma industry well before most trade titles had serious web operations. Over more than 25 years it has grown into one of the most widely read digital news sources for pharmaceutical professionals, complementing PMGroup's print title Pharmaceutical Marketing Europe (PME) and its awards programmes.

Ownership and funding model

PMLiVE is owned and operated by PMGroup Worldwide Ltd, an independent healthcare publishing and communications business. The site is free to read for industry professionals and funded by advertising, sponsored content and commercial partnerships with pharmaceutical companies and industry suppliers. Its integration with PMGroup's wider portfolio — including the PME awards and industry events — gives it commercial synergies across publishing, recognition programmes and live events.

Editorial focus and coverage areas

PMLiVE covers the commercial side of the pharmaceutical industry: marketing strategy, brand management, market access and pricing, digital and multichannel marketing, sales force effectiveness, and the corporate strategies of the major drugmakers. Its daily news tracks appointments, agency wins, campaign launches, regulatory developments affecting marketing, and the industry's adoption of new channels from social media to AI. Features and analysis explore the big strategic questions — from the future of the sales rep to the impact of digital on physician engagement.

Notable journalists and contributors

PMLiVE's editorial team comprises specialist B2B journalists covering the pharma marketing beat, supported by contributors from across the healthcare communications industry. The platform's authority rests on its journalists' deep understanding of pharmaceutical marketing's unique constraints — the regulatory frameworks, the payer landscape and the evolving digital toolkit — and on PMGroup's decades of relationships across the sector.

Audience and reach

PMLiVE's readership is the pharmaceutical industry's commercial functions: marketers, brand managers, market-access specialists, digital leads and agency professionals. Its daily news emails are essential reading for UK pharma marketers, and its website reaches a global audience of industry professionals. The platform's association with the PME and PMEA awards extends its reach into the senior ranks of pharma commercial leadership.

Business model

PMLiVE is a free, advertising-supported B2B publication, with revenue from display advertising, sponsored content, webinars and commercial partnerships. Its business is strengthened by PMGroup's awards franchises: the PMEA (Pharmaceutical Marketing Excellence Awards) and the PME awards are major industry events generating entries, sponsorship and table revenues. This publishing-plus-awards model is a proven formula in B2B media, giving PMGroup multiple touchpoints with its market.

Digital platforms, podcasts and newsletters

PMLiVE publishes through pmlive.com, with daily news, features, blogs and video content, and distributes its journalism via email newsletters that deliver the day's industry news to subscribers' inboxes. The platform's digital operation includes webinars and virtual events, extending its reach beyond written journalism into live and on-demand professional content.

Awards and recognition

PMLiVE's parent PMGroup runs two of the pharmaceutical industry's most respected awards programmes: the PMEA (Pharmaceutical Marketing Excellence Awards), which recognise outstanding marketing and commercial achievement in pharma, and the PME awards. These programmes are benchmarks of excellence in the industry, and PMLiVE's role as their media platform reinforces its authority. The site itself is widely regarded as a leading digital news source for pharma professionals.

Industry role and reputation

PMLiVE functions as the daily trade paper for pharmaceutical marketing: the first read of the day for brand managers and agency staff, the record of campaigns and appointments, and — through the PMEA and PME awards — the arbiter of excellence in pharma commercial practice. Its 25-year history gives it deep credibility, and its independence within PMGroup's specialist portfolio keeps it focused on the industry it serves.

Outlook

PMLiVE continues to publish daily news for pharma professionals as the industry's commercial model evolves — with AI, omnichannel marketing and changing payer dynamics reshaping pharmaceutical marketing. Its combination of daily journalism, awards and events positions it to remain central to the industry's professional life for years to come.

The PMEA and PME awards: benchmarking pharma excellence

PMGroup's awards programmes — the PMEA (Pharmaceutical Marketing Excellence Awards) and the PME awards — are among the most coveted honours in pharmaceutical commercial practice, and PMLiVE is their media platform. The PMEA recognises outstanding achievement in pharmaceutical marketing: the campaigns, brand teams, agencies and individuals that set the standard for the industry. Categories span the disciplines of modern pharma marketing — brand strategy, digital and multichannel excellence, market access, patient engagement and agency performance — and winning is a career-defining accolade for marketers and a powerful new-business asset for agencies. The PME awards, associated with PMGroup's Pharmaceutical Marketing Europe title, similarly celebrate excellence with a European perspective. The awards' judging processes, involving senior industry figures, give the programmes credibility; the gala ceremonies are major fixtures of the pharma commercial calendar. For PMGroup, the awards are both a commercial engine — entries, sponsorship and table sales — and an editorial one: PMLiVE's coverage of shortlists, winners and judging debates generates some of its most-read content each year, while the awards reinforce the platform's authority as the industry's judge of quality. The relationship is symbiotic: the awards need a trusted media platform to give them profile, and the platform needs the awards to demonstrate its centrality to the industry. For pharma marketers, the cycle of entering, shortlisting and winning structures professional ambition; for agencies, PMEA recognition is a differentiator in pitches. In an industry where marketing operates within tight regulatory constraints, the awards also serve a substantive purpose: they identify and disseminate best practice, showing what excellence looks like when creativity must work within the rules. PMLiVE's role at the centre of this ecosystem — reporting the news daily and crowning the best annually — makes it far more than a news website: it is part of the industry's professional infrastructure.

PMLiVE's 1999 launch placed it among the pioneers of digital B2B publishing — building a daily online news operation for pharma professionals when most trade titles were still figuring out the web. That early start gave it a lasting first-mover advantage: by the time rivals built serious digital operations, PMLiVE was already the industry's daily habit. PMGroup's wider portfolio — the Pharmaceutical Marketing Europe title, the PMEA and PME awards, events and communications services — created a virtuous circle in which journalism, recognition and live gatherings reinforced one another. For the marketers, agencies and suppliers who make up its audience, PMGroup became less a publisher and more a professional home: the news they read, the awards they entered, the events they attended. As pharma marketing confronts AI-driven personalisation, tighter regulation and the shift to omnichannel engagement, PMLiVE's quarter-century of accumulated expertise — in both journalism and the awards that define excellence — keeps it at the centre of the industry's commercial conversation.